DuPont Completes Major Divestiture of Aramids Business
In a significant move within the material science sector, DuPont (NYSE: DD) has finalized the divestiture of its Aramids business, which encompasses the well-known brands Kevlar® and Nomex®. This transaction has been valued at approximately $1.8 billion and has been handed over to Arclin, a prominent company backed by an affiliate of TJC, L.P.
The completion of the sale allows DuPont to realize substantial pre-tax cash proceeds totaling around $1.2 billion, subject to standard transaction adjustments. Additionally, the deal includes a note receivable of $300 million and a non-controlling common equity stake in Arclin, valued at $325 million, representing about 16% ownership. The results from the Aramids business have already been reported as discontinued operations starting from the third quarter of 2025, both for current and historical periods, aligning with DuPont's strategic restructuring plans.
About Arclin
Arclin stands as a leader in materials science, specializing in engineered products and polymer technologies across multiple sectors, including construction, agriculture, and transportation infrastructure. With its headquarters in Alpharetta, Georgia, Arclin operates globally, boasting facilities and offices throughout North and South America, Europe, and Asia. The company prides itself on its ability to offer specialized materials that cater to various industries such as pharmaceuticals, electronics, and design. Interested parties can find more about Arclin at
www.arclin.com.
Insights into TJC, L.P.
The buyer, TJC, L.P., formerly known as The Jordan Company, has a rich history of collaborating with CEOs and entrepreneurs across diverse sectors, including healthcare, logistics, and digital power infrastructure. With assets under management amounting to $30.9 billion as of late September 2025, TJC's investment team has been working together for over 24 years and has made significant investments in more than 90 firms. Their offices are located in major cities such as New York, Chicago, Miami, and Stamford. More information regarding TJC can be found at
www.tjclp.com.
Conclusion
The sale of the Aramids business signifies a transformative phase for DuPont as it focuses on redefining its operational landscape. As a global leader in innovation, DuPont continues to explore avenues that enhance its core markets, which include healthcare, water, and construction. This divestiture is expected to streamline the company’s focus, allowing it to allocate resources more efficiently towards growth in these key sectors. Additional information about DuPont can be accessed at
www.dupont.com. Investors can also find pertinent updates in the Investor Relations section at
investors.dupont.com.
DuPont remains committed to delivering advanced solutions that shed light on industry challenges and improve everyday life. With the completion of this strategic divestiture, all eyes remain on how DuPont will navigate its next steps in the ever-evolving landscape of global business operations.